Evolus Logo Nov 2018.png
Evolus Reports Second Quarter 2021 Results and Provides Business Update
August 04, 2021 16:05 ET | Evolus
Record Quarter: Net Revenue Grew 235% Year-over-Year to $26.1 Million Exceeded Annualized Revenue Run Rate Goal of $100 Million Low Q2 Cash Burn Resulting in $131.7 Million Cash Position at...
Evolus Logo Nov 2018.png
Evolus to Report Second Quarter 2021 Results and Provide Business Update
July 22, 2021 09:00 ET | Evolus
NEWPORT BEACH, Calif., July 22, 2021 (GLOBE NEWSWIRE) -- Evolus, Inc. (NASDAQ: EOLS), a performance beauty company with a customer-centric approach focused on delivering breakthrough products,...
Evolus Logo Nov 2018.png
Evolus Announces Appointment of David K. Erickson as Vice President, Investor Relations
June 30, 2021 09:00 ET | Evolus
NEWPORT BEACH, Calif., June 30, 2021 (GLOBE NEWSWIRE) -- Evolus, Inc. (Nasdaq: EOLS), a performance beauty company with a customer-centric approach focused on delivering breakthrough products, today...
Evolus Logo Nov 2018.png
Peer Reviewed Article Highlights Efficacy and Safety of Jeuveau® in Patients with Skin of Color
June 24, 2021 09:00 ET | Evolus
NEWPORT BEACH, Calif., June 24, 2021 (GLOBE NEWSWIRE) -- Evolus, Inc. (Nasdaq: EOLS), a performance beauty company with a customer-centric approach focused on delivering breakthrough products, today...
Evolus Logo Nov 2018.png
Evolus Appoints Dan Stewart as Vice President and General Manager, International
May 19, 2021 09:00 ET | Evolus
NEWPORT BEACH, Calif., May 19, 2021 (GLOBE NEWSWIRE) -- Evolus, Inc. (Nasdaq: EOLS), a performance beauty company with a customer-centric approach focused on delivering breakthrough products, today...
Evolus Logo Nov 2018.png
Evolus Reports First Quarter 2021 Results and Provides Business Update
May 12, 2021 16:05 ET | Evolus
Q1 2021 Net Revenues of $12.2 million, Despite Half-Quarter ITC Impact Full Resolution of International Trade Commission (ITC) Case Restructured Balance Sheet with March 31, 2021 Pro Forma Cash...
Evolus Logo Nov 2018.png
Aesthetic Surgery Journal Publishes Long Term Safety and Efficacy Data of Jeuveau® for the Treatment of Moderate to Severe Frown Lines
May 12, 2021 09:00 ET | Evolus
NEWPORT BEACH, Calif., May 12, 2021 (GLOBE NEWSWIRE) -- Evolus, Inc. (NASDAQ: EOLS), a performance beauty company with a customer-centric approach focused on delivering breakthrough products, today...
Evolus Logo Nov 2018.png
Evolus to Report First Quarter 2021 Results and Provide Business Update
May 04, 2021 16:05 ET | Evolus
NEWPORT BEACH, Calif., May 04, 2021 (GLOBE NEWSWIRE) -- Evolus, Inc. (NASDAQ: EOLS), a performance beauty company with a customer-centric approach focused on delivering breakthrough products,...
Evolus Logo Nov 2018.png
Evolus to Participate in the 7th Annual Truist Securities Life Sciences Summit
April 29, 2021 16:05 ET | Evolus
NEWPORT BEACH, Calif., April 29, 2021 (GLOBE NEWSWIRE) -- Evolus, Inc. (NASDAQ: EOLS), a performance beauty company with a customer-centric approach focused on delivering breakthrough products,...
Evolus Logo Nov 2018.png
Evolus Announces Pricing of Public Offering of Common Stock
April 21, 2021 22:30 ET | Evolus
NEWPORT BEACH, Calif., April 21, 2021 (GLOBE NEWSWIRE) -- Evolus, Inc. (Nasdaq: EOLS) announced today the pricing of its public offering of 9,000,000 shares of its common stock at a public offering...